Clinical Trials Information
For information about clinical trials using Cephalon products--sponsored by institutions, the US government, and Cephalon--consult the list of links to the National Institute of Health www.clinicaltrials.gov website.
Click on the title of the study to learn about recruitment status, sites, criteria for participation, and contact information.
Cephalon is recruiting patients for clinical trials in the following areas:
Cancer
- Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
- Open-Label Study of Oral CEP-701 (lestaurtinib) in Patients with Polycythemia Vera or Essential Thrombocytosis
- Study of Low-Dose Cytarabine in Combination With Arsenic Trioxide, Compared With Low-Dose Cytarabine Alone, for the Treatment of Elderly Patients With Acute Myeloid Leukemia (AML)
Central Nervous System
- Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Adults With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome With Comorbid Major Depressive Disorder or Dysthymic Disorder
- Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
- Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder
- Study to Evaluate the Effects of Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance in Adults With OSAHS Who Use nCPAP Therapy